CPI-100
/ Coordination Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 20, 2022
Study of CPI-100 in Patients With Advanced Tumors
(clinicaltrials.gov)
- P1 | N=36 | Completed | Sponsor: Coordination Pharmaceuticals, Inc. | Recruiting ➔ Completed | Trial completion date: Dec 2022 ➔ Jun 2022
Trial completion • Trial completion date • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1